Fluorocarbon-Based Blood Substitutes: What Progress?
Open Access
- 1 May 1991
- journal article
- editorial
- Published by SAGE Publications in The International Journal of Artificial Organs
- Vol. 14 (5) , 255-258
- https://doi.org/10.1177/039139889101400501
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- A phase I/II study of the use of Fluosol® as an adjuvant to radiation therapy in the treatment of primary high-grade brain tumorsInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Phase i/ii study of fluosol®-DA and 100% oxygen as an adjuvant to radiation in the treatment of advanced squamous cell tumors of the head and neckInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Liver, spleen, and vessels: preliminary clinical results of CT with perfluorooctylbromide.Radiology, 1989
- Potential role of perfluorooctylbromide in the detection and characterization of liver lesions with CT.Radiology, 1989
- Intravenous fat emulsions and lung functionCritical Care Medicine, 1988
- Lung Vascular Effects of Lipid Infusion in Awake LambsPediatric Research, 1987
- Fluosol-DA as a Red-Cell Substitute in Acute AnemiaNew England Journal of Medicine, 1986
- Fat Emulsions and Lung FunctionClinics in Chest Medicine, 1986
- Reassessment of Criteria for the Selection of Perfluorochemicals for Second‐Generation Blood Substitutes: Analysis of Structure/Property RelationshipsArtificial Organs, 1984
- The reaction of perfluoroalkylcopper compounds with 1-bromo-1-perfluoroalkylethylenesTetrahedron, 1973